Supernus Pharm (SUPN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SUPN | AMPH | TSHA | ||
| Company | Supernus Pharm | Amphastar Pharma | Taysha Gene Therapies Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 29.96 | 40.70 | 2.53 | ||
| High | 30.40 | 41.20 | 2.54 | ||
| Low | 29.82 | 40.43 | 2.32 | ||
| Last | 30.26 | 41.00 | 2.35 | ||
| Change | +0.31 | +0.09 | -0.18 | ||
| % Change | +1.04% | +0.22% | -7.11% | ||
| Volume | 201,700 | 218,200 | 794,000 | ||
| 20-Day Average Volume | 353,285 | 348,425 | 2,034,560 | ||
| Previous Close | 29.95 | 40.91 | 2.53 | ||
| Industry | Medical - Generic Drugs | Medical - Generic Drugs | Medical - Generic Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 31.45 | 41.13 | 2.72 | ||
| 20-Day Raw Stochastic | 27.82% | 40.16% | 16.33% | ||
| 20-Day Relative Strength | 46.34% | 40.61% | 45.89% | ||
| Weighted Alpha | -11.81 | -4.90 | -2.25 | ||
| Today's Opinion | 56% Buy | 100% Sell | 56% Buy | ||
| Previous Opinion | 56% Buy | 100% Sell | 56% Buy | ||
| Last Month's Opinion | 88% Buy | 88% Sell | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.34% since 04/17/24 | +2.37% since 04/17/24 | -4.08% since 04/17/24 | ||
| Low | 28.63 on 04/18/24 | 38.43 on 04/18/24 | 2.14 on 04/19/24 | ||
| High | 31.84 on 04/23/24 | 41.20 on 04/24/24 | 2.61 on 04/23/24 | ||
| 1-Month | |||||
| %Chg | -12.34% since 03/22/24 | -6.18% since 03/22/24 | -27.69% since 03/22/24 | ||
| Low | 28.63 on 04/18/24 | 38.43 on 04/18/24 | 2.14 on 04/19/24 | ||
| High | 34.98 on 03/25/24 | 44.83 on 03/28/24 | 3.43 on 03/25/24 | ||
| 3-Month | |||||
| %Chg | +7.80% since 01/24/24 | -25.75% since 01/24/24 | +59.86% since 01/24/24 | ||
| Low | 26.27 on 02/28/24 | 38.43 on 04/18/24 | 1.41 on 02/14/24 | ||
| High | 35.44 on 03/21/24 | 56.45 on 02/12/24 | 3.55 on 03/01/24 | ||
| 6-Month | |||||
| %Chg | +26.08% since 10/24/23 | -9.59% since 10/24/23 | +4.44% since 10/24/23 | ||
| Low | 21.99 on 10/27/23 | 38.43 on 04/18/24 | 1.27 on 11/14/23 | ||
| High | 35.44 on 03/21/24 | 65.92 on 01/05/24 | 3.55 on 03/01/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 1,639,313 | 1,999,108 | 473,156 | ||
| Shares Outstanding, K | 54,735 | 48,866 | 187,018 | ||
| Annual Sales | 607,520,000 | 644,400,000 | 15,450,000 | ||
| Annual Net Income | 1,320,000 | 137,550,000 | -111,570,000 | ||
| Last Quarter Sales | 164,310,000 | 178,110,000 | 3,600,000 | ||
| Last Quarter Net Income | 1,170,000 | 36,170,000 | 47,740,000 | ||
| 60-Month Beta | 0.99 | 0.84 | 0.29 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.02 on 02/27/24 | 0.88 on 02/28/24 | 0.35 on 03/19/24 | ||
| Latest Earnings Date | 05/14/24 | 05/14/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.43 | 0.00 | ||